Pep2Tango Therapeutics Inc.

Private

Potomac, MarylandHealthcare & Life Scienceshttps://www.pep2tango.com/

Last Round

VC Round

Nov 21, 2024

Company Overview

Pep2Tango Therapeutics Inc. is a biotechnology company developing next-generation unimolecular multi-agonist peptides for obesity and associated metabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

peptide therapiesobesity treatmenttetra-receptor agonistunimolecular peptideGLP-1 agonistanti-obesity drugsmuscle-sparing weight lossnext-gen obesity drugmulti-agonist obesity drugGIP agonistmetabolic disorder treatmentdrug discoverypreclinical biotechnologyamylin agonistcalcitonin agonist

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pep2Tango Therapeutics Inc. Comparables

Compare Pep2Tango Therapeutics Inc. with similar companies based on industry and business-model similarity.

Pep2Tango Therapeutics Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
AstraZeneca	83%
Alveus Therapeutics	82%
Antag Therapeutics	75%

View all Comparables

Pep2Tango Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Nov 21, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Cristina Rondinone

Founder And CEO

Founding Team

Pep2Tango Therapeutics Inc. Investors

Notable investors and investment history

Pep2Tango Therapeutics Inc. investors
Investor	Rounds
Versant Ventures	VC Round

View all Investors

Pep2Tango Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pep2Tango Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pep2Tango Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPotomac, Maryland

Employee Range4

Year Founded2021

Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?